 NEW YORK, Dec. 29, 2020 PRNewswire -- Scopus BioPharma Inc. Nasdaq: SCPS today announced the appointment of additional members to its Board of Directors. Scopus is a biopharmaceutical company whose lead drug candidate is a novel, targeted immuno-oncology gene therapy for the treatment... 